FDA — authorised 28 June 1951
- Application: NDA007707
- Marketing authorisation holder: ABBVIE
- Local brand name: PHENURONE
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Phenurone on 28 June 1951
Yes. FDA authorised it on 28 June 1951; FDA has authorised it.
ABBVIE holds the US marketing authorisation.